CARsgen Therapeutics Holdings Ltd. had a revenue of 74.70M in the quarter ending Dec 31, 2025, with 46.58%. This bring the company's revenue in the last twelve months to 125.66M, Decreased 77.81%. In the fiscal year ending Dec 31, 2025, CARsgen Therapeutics Holdings Ltd. had annual revenue of 125.66M with 218.74% growth.